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ABSTRACT Candida albicans is a human fungal pathogen that does not follow the
universal codon usage, as it translates the CUG codon into serine rather than leu-
cine. This makes it difﬁcult to study protein-protein interactions using the standard
yeast two-hybrid (Y2H) system in the model organism Saccharomyces cerevisiae. Due
to the lack of adapted tools, only a small number of protein-protein interactions
(PPIs) have been detected or studied using C. albicans-optimized tools despite the
importance of PPIs to understand cell biology. However, with the sequencing of the
whole genome of C. albicans, the availability of an ORFeome collection containing
5,099 open reading frames (ORFs) in Gateway-adapted donor vectors, and the cre-
ation of a Gateway-compatible C. albicans-speciﬁc two-hybrid (C2H) system, it be-
came possible to study protein-protein interactions on a larger scale using C. albi-
cans itself as the model organism. Erroneous translations are hereby eliminated
compared to using the S. cerevisiae Y2H system. Here, we describe the technical ad-
aptations and the ﬁrst application of the C2H system for a high-throughput screen,
thus making it possible to screen thousands of PPIs at once in C. albicans itself. This
ﬁrst, small-scale high-throughput screen, using Pho85 as a bait protein against 1,646
random prey proteins, yielded one interacting partner (Pcl5). The interaction found
with the high-throughput setup was further conﬁrmed with a low-throughput C2H
experiment and with a coimmunoprecipitation (co-IP) experiment.
IMPORTANCE Candida albicans is a major fungal pathogen, and due to the rise of
fungal infections and emerging resistance to the limited antifungals available, it is
important to develop novel and more speciﬁc antifungals. Protein-protein interac-
tions (PPIs) can be applied as very speciﬁc drug targets. However, because of the
aberrant codon usage of C. albicans, the traditional yeast two-hybrid system in Sac-
charomyces cerevisiae is difﬁcult to use, and only a limited number of PPIs have
been described in C. albicans. To overcome this, a C. albicans two-hybrid (C2H) sys-
tem was developed in 2010. The current work describes, for the ﬁrst time, the appli-
cation of the C2H system in a high-throughput setup. We hereby show the useful-
ness of the C2H system to investigate and detect PPIs in C. albicans, making it
possible to further elucidate protein networks in C. albicans, which has the potential
to lead to the development of novel antifungals which speciﬁcally disrupt PPIs im-
portant for virulence.
KEYWORDS Candida albicans, Candida albicans two-hybrid (C2H), ORFeome, high-
throughput, protein-protein interactions, yeast two-hybrid
Candida albicans is a pleiomorphic commensal diploid fungus and also an oppor-tunistic pathogen leading to superﬁcial infections but also life-threatening ones in
immunocompromised patients (1, 2). C. albicans is among the four most deadly fungi,
with mortality rates up to 50%, and responsible for the fourth most common nosoco-
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mial infection (1–3). In general, fungal infections are on the rise due to the advances in
medical and intensive care, organ donation, implanted medical devices, and treatments
of life-threatening (bacterial) infections (1, 4). Despite the rising impact of fungi, they
are often ignored (1), and the development of antifungal drugs proves to be very
challenging (5). At the moment, there is not a single antifungal vaccine on the market,
only a limited number of antifungals are currently in use to combat fungal infections,
and resistance is on the rise (1, 6).
In-depth knowledge about the function of proteins is crucial for the development of
novel antifungals. A promising novel technique to develop very speciﬁc antifungals is
targeting protein-protein interactions (PPIs) with small molecules (7–9). Information on
PPIs is thus crucial for developing such antifungals, and the yeast two-hybrid (Y2H)
system can play a pivotal role in this (10). For several organisms, large-scale or
genome-wide Y2H studies to investigate PPIs have been published, contributing to an
in-depth knowledge of, e.g., protein functions and cellular pathways (11–14). However,
PPI studies are almost nonexistent for C. albicans (15, 16). The BioGRID database reports
only 163 interactions (15), while the STRING database does not even mention C. albi-
cans as a searchable organism (17), despite being one of the most studied fungal
pathogens and even serving as a model organism (18). The lack of studied interactions
is mainly due to C. albicans having a nonstandard CUG codon usage (translating CUG
as serine rather than leucine most of the time), a low transformation efﬁciency, and
unstable episomal plasmids, hindering the application of commonly used techniques
such as the Y2H system (19–23). Besides the lack of PPI studies, the majority of
genes/proteins are still uncharacterized (16, 19). Major contributing factors, next to the
aberrant codon usage and lack of usable plasmids, are the C. albicans complex life cycle,
having a heterozygous diploid nature, and the absence of a complete sexual cycle.
These all make it hard to use standard genetic techniques (18, 20, 21, 24). In recent
years, new technologies have been developed or adapted for use in C. albicans (18, 24,
25). Several of those techniques are focusing on PPIs (19, 26–28). One such technique
is the speciﬁc C. albicans two-hybrid (C2H) system, which overcomes the problems
associated with using the traditional Y2H system (19).
With the sequencing of the whole genome (16, 29–31), the availability of a Gateway-
adapted C. albicans ORFeome containing 83% of the currently annotated coding
sequences, and the adaption of the C2H system to a high-throughput setup, it became
possible to screen PPIs on a larger scale (32). Here, we show the potential of the C2H
system to detect PPIs by presenting the ﬁrst large-scale application of this C2H system.
Indeed, we have performed a high-throughput screen using a single bait protein
(Pho85) against 1,646 random prey proteins in a mating approach setup. This led to the
discovery of one new PPI that was further conﬁrmed by a coimmunoprecipitation
(co-IP) experiment. These results demonstrate the potential of the C2H system to screen
for novel PPIs in a high-throughput setup, aiding the elucidation of protein networks in
C. albicans. In-depth knowledge of PPIs and the function of proteins will aid the
elucidation of many uncharacterized genes and gene products of C. albicans, leading to
a better understanding of this commensal organism that can thrive as a major and
deadly pathogen when the opportunity arises.
RESULTS
Generation of prey library. With the available ORFeome collection (32), a prelim-
inary, random library of prey-harboring C. albicans strains was generated. Using the LR
reaction (Gateway system), 1,646 open reading frames (ORFs) were transferred from the
pDONR207-XX (XX denoting a certain ORF) plasmids to the prey plasmid pC2HP-GC
(32). Resulting prey plasmids pC2HP-XX were then transformed into mating-compatible
strain SC2H3a-pWOR1. Transformants were selected on SC-Arg agar plates at 23°C for
5 days and stored in 96-well plates at 80°C. Each well contains one speciﬁc prey-
harboring strain.
A bait plasmid containing the PHO85 ORF was constructed and transformed into the
mating-compatible strain SC2H3-pWOR1. Transformants were selected on SC-Leu
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agar plates at 23°C for 5 days and stored in a 96-well plate, and so a matrix-approach
C2H screen was possible.
Setup of a high-throughput C. albicans C2H screen. In 2010, the C2H system was
described to study PPIs in C. albicans, leading to several novel interactions that were
detected using this system. However, the system was limited to a low-scale setup (19).
To overcome this limitation, the original C2H vectors were made Gateway compatible
and inducible mating-competent C. albicans strains were created (32). The latter is
important since the low transformation efﬁciency and unstable episomal plasmids
make it difﬁcult to perform a traditional pooled-style PPI screen. In the previously
described study (32), the mating-compatible diploid strains harboring a bait or prey
plasmid were mixed in liquid Spider medium without the addition of doxycycline (Dox)
(see also below) (32). This approach is, however, less feasible for a high-throughput
setup since mating in 96-well plates in liquid culture proved to be inefﬁcient. In order
to overcome this limitation, the mating of prey and bait was performed on Spider agar
medium. Prey- and bait-harboring strains were manually transferred with a 96-replicate
pinner, respectively, from SC-Arg and SC-Leu to Spider-plus-Dox agar plates and
incubated for 5 to 6 days at 23°C to induce mating and the generation of tetraploids.
The addition of doxycycline (Dox) is necessary for the induction of opaque switching by
the WOR1 regulator to stimulate mating by forming opaque cells (32). When doxycy-
cline was omitted from the Spider medium, the mating efﬁciency dropped substantially
even if Dox was added in the precultures of the prey and baits on SC-Arg or SC-Leu
agar. Growing the cells at 23°C aids further in stabilizing the opaque cells, preventing
them reverting to white cells that are less mating efﬁcient (33). The cells were
subcultured on SC-Arg-Leu agar plates to select for resulting tetraploids at 30°C for 2
to 3 days. Finally, the cells were transferred in duplicate to SC-Met-His and/or SC-Met-
Cys-His medium and grown for up to 14 days at 30°C to screen for potential PPIs.
Growth on medium lacking histidine is indicative of PPI. The selection between
SC-Met-His and SC-Met-Cys-His medium depends on the background growth of the
particular bait used. For baits showing a high background growth, it is advisable to use
only SC-Met-His medium as this gives less expression of the bait (and prey) construct
(34). A preliminary test in which the bait plasmid-harboring C. albicans strain is spotted
on SC-Met-His and SC-Met-Cys-His should always be performed before starting with the
C2H screen to detect autoactivation and strong background growth. It is important to
keep in mind that the tetraploid strains formed during the high-throughput screen are
less stable (and grow less well) than the SC2H3 diploid strain, cotransformed with bait
and prey plasmids, during the two-step validation process (described below). It is thus
possible that for the mating approach, SC-Met-Cys-His medium is needed, while for the
cotransformation approach, SC-Met-His is required. To screen for potential interactions,
plates were kept at 30°C for up to 14 days and (speed of) growth was scored relative
to the background growth. All steps during the high-throughput screen were manually
performed using a 96-replicate pinner since C. albicans forms dry, rubber-like colonies
on Spider medium (35), making it harder to use an automated, robotic replicate system.
Figure 1 provides an overview of the setup of a genome-wide two-hybrid screen.
False positives are a common problem with Y2H high-throughput screens. To
decrease the amount of false positives, 3-aminotriazole (3-AT), an inhibitor of the HIS3
gene product, is usually used (11); however, since the C2H system uses the HIS1 marker
(19) and not the HIS3 marker, a stringent two-step validation protocol was designed.
When growth was visible on SC-Met-His and SC-Met-Cys-His plates in the high-
throughput C2H screen, indicating potential PPI, the corresponding bait- and prey-
harboring strains were retested manually by spotting them next to each other, using a
pipette tip, on fresh Spider-plus-Dox agar medium. After mating, the resulting tetrap-
loids were grown on SC-Leu-Arg followed by selection on SC-Met-His and SC-Met-Cys-
His to recheck the interaction (step 1). This extra step will signiﬁcantly limit the number
of false positives. In order to further validate the potential interactions identiﬁed and
remove residual false positives, an independent C2H experiment was performed (step
A High-Throughput Candida albicans Two-Hybrid System
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2). In short, the bait and prey plasmids were cotransformed into the diploid SC2H3
strain and at least 3 independent transformants were further screened and checked for
interaction followed by a ﬁnal 5-fold dilution series spot assay on SC-Met-Cys-His and
SC-Met-His (Fig. 2). The ﬁrst step of the two-step validation protocol can be omitted
when background growth during the initial high-throughput screen is almost absent.
A potential third extra step to verify a potential interaction is to swap the bait and prey
proteins. However, reversing bait and prey does not always lead to conﬁrmation of the
interaction and the results of such a swap experiment should be interpreted with care
(11). The high-throughput screen followed by the two-step validation protocol already
reduces false positives enormously (see below). However, to further conﬁrm the
identiﬁed interactions a different technique such as bimolecular ﬂuorescence comple-
mentation (BiFC) (26) or co-IP (19) could be used. We have used a co-IP experiment as
a ﬁnal validation step.
A high-throughput C2H screen using Pho85 as the bait protein. To demonstrate
the potential of C2H screening in a high-throughput setup, a random set of preys was
screened against a speciﬁcally selected bait protein, Pho85. The selection of Pho85 as
the bait was based on two criteria. The ﬁrst important one is that Pho85 is an essential
cyclin-dependent protein kinase (36). The second is the fact that the functional Sac-
charomyces cerevisiae Pho85 homologue has been shown to have several hundred
interactors (37).
The high-throughput PPI screen was performed in a matrix setup in which bait
protein Pho85 was mated with 1,646 random preys. Of these 1,646 prey-expressing
strains, a total of 1,478 (90%) mated successfully with the Pho85 bait-expressing strain
and formed tetraploids surviving on SC-Leu-Arg. From these 1,478 tetraploid strains, 15
showed promising growth on SC-Met-Cys-His and/or SC-Met-His medium. These 15
potential interactions were then manually retested. Only 5 of those 15 showed (weak)
growth compared to the background growth and were kept for the second validation
FIG 1 Schematic representation of the high-throughput C2H screen. Bait- and prey-harboring mating-
competent C. albicans cells are spotted on SC-Leu or SC-Arg followed by replating on Spider-plus-Dox
medium for mating. The mated cells (tetraploids) are then selected on SC-Leu-Arg prior to being
screened for interaction. Interaction is screened on SC-Met-His or/and SC-Met-Cys-His medium. Growth
on medium lacking histidine is indicative of interaction. Colonies growing faster and/or larger than
background growth are kept for the next step, the two-step validation protocol. See the text for more
details.
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step (see Data Set S1 in the supplemental material). This ﬁnal step led to one clear
interaction partner: Pcl5, a cyclin (Fig. 3). Interestingly an interaction between the yeast
orthologues of Pho85 and Pcl5 was already shown in S. cerevisiae (38, 39), and the Pcl5
protein has been shown to be a putative cyclin for Pho85 in C. albicans, similarly to its
role in S. cerevisiae (40). Here, we provide evidence for the physical interaction between
Pho85 and Pcl5 in C. albicans.
The four other potential interactions did not show growth on selective medium in
the second step of the validation protocol. This, together with the reduction from 15
potential interactions to 5 in the ﬁrst step of the two-step validation protocol, proves
the strength and importance of this protocol. The two-step validation protocol clearly
reduces false positives but can also lead to false negatives, which is another problem
when using a Y2H system (11, 41, 42).
FIG 2 Schematic representation of the ﬁrst step of the two-step validation protocol. Potential interacting
bait and preys are manually spotted next to each other on Spider-plus-Dox medium followed by
selection on SC-Leu-Arg. Successfully mated cells are then screened for potential interaction on SC-Met-
His and SC-Met-Cys-His medium. Baits and preys that show potential interaction (growth on SC-Met-His
and/or SC-Met-Cys-His) are then retested by a cotransformation in step 2 of the validation protocol. For
this, both the bait and prey plasmids are cotransformed into a diploid SC2H3 strain and selected on
SC-Leu-Arg, after which interaction is screened on SC-Met-Cys-His and/or SC-Met-His. In a ﬁnal step, a
spot assay can be performed.
FIG 3 Spot assays using diploids created by cotransforming bait and prey plasmids in SC2H3, showing the interaction
between bait Pho85 and prey Pcl5. No growth on selective medium (i.e., without histidine to select for interaction) is visible
in strains expressing Pho85 and an empty prey plasmid (second row) or when only the Pcl5 prey is expressed (third row).
Spot assays were performed in a 5-fold dilution. The MET3 promoter from which the hybrid genes are expressed is
repressed in the presence of cysteine and methionine. Omitting both amino acids results in strong expression (middle
column). Omitting only methionine results in a lower expression level, and as can be seen in the last column, there is less
growth under this condition because of lower expression of bait and prey.
A High-Throughput Candida albicans Two-Hybrid System
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To further validate the identiﬁed interaction, a co-IP experiment was performed,
conﬁrming the interaction between Pho85 and Pcl5 (Fig. 4). In an independent exper-
iment, we also switched bait and prey, creating Pcl5 bait- and Pho85 prey-containing
plasmids, which were used to perform a cotransformation experiment followed by a
spot assay. Growth was again detected, indicating interaction between the Pcl5 bait
and the Pho85 prey, conﬁrming the already-validated interaction between proteins
Pho85 and Pcl5. Table 1 shows the identiﬁed interaction.
DISCUSSION
Despite C. albicans being an important human fungal pathogen and its whole
genome being sequenced, the majority of C. albicans genes and proteins remain
uncharacterized, largely limited by the aberrant codon usage (16). Yet, a better com-
prehension of the regulation and function of proteins can lead to a better understand-
ing of C. albicans and its role in being both a commensal and pathogenic organism (43,
44). This can be achieved by an in-depth study of proteins and PPIs. Besides offering
information on the biology of an organism, PPIs can also be exploited as the target of
drugs such as antifungals (7, 9, 45, 46). Antifungals that can target the pathogen very
speciﬁcally are increasingly needed with emerging fungal pathogens and rising resis-
tance (1, 47). The creation of these very speciﬁc antifungals is a signiﬁcant challenge
given the host-like eukaryotic nature of fungal pathogens. Perhaps, the answer to this
problem lies in the development of small molecules targeting PPIs (7, 47, 48). Several
FIG 4 Coimmunoprecipitation of Pho85 and Pcl5. The interaction between bait Pho85 (LexA-HA-Pho85)
and prey Pcl5 (VP16-FLAG-Pcl5) was conﬁrmed in a co-IP experiment. Lane 1 shows the positive control
of a co-IP of Pcl5 (IP with anti-FLAG). Lane 2 shows a co-IP of Pcl5 (IP with anti-HA). Lane 3 shows a control
co-IP of strain SC2H3 transformed with the bait plasmid (pC2HB-Pho85) and an empty prey plasmid
(pC2HP-GC) (IP with anti-HA). Lane 4 shows a control co-IP of strain SC2H3 transformed with an empty
bait plasmid (pC2HB-GC) and the Pcl5 prey plasmid (pC2HP-Pcl5) (IP with anti-HA). The size ladder is
shown in lane L. The VP16-FLAG-Pcl5 construct is approximately 47 kDa in size. The antibody (AB) used
for Western blotting is indicated on the right side; the antibody for immunoprecipitation is indicated
below the blot.
TABLE 1 Interaction between Pho85 bait and Pcl5 prey detected using high-throughput mating C2H screening and further checked
with the two-step low-throughput conﬁrmation protocola
Bait protein (pC2HB-XX) Prey protein (pC2HP-XX)
C2H result for spot
assay of SC2H3 diploids
Name ORF no. BCCM accession no. Name ORF no. BCCM accession no. SC-M-H SC-M-C-H
Pho85 orf19.6846 LMBP 10482 Pcl5 orf19.4012 LMBP 10501 G (W) G
Pcl5 orf19.4012 LMBP 10577 Pho85 orf19.6846 LMBP 10593 G (W) G
aDuring the high-throughput screen, the interaction was detected on an SC-Met-Cys-His agar plate. On the SC-Met-His agar plate, the growth was very weak and
difﬁcult to distinguish against the background growth. The interaction was then further validated with a low-throughput screen using tetraploids followed by a
cotransformation and a spot assay of the diploid SC2H3 strain transformed with both the bait and prey plasmids. The interactions between bait Pho85 and prey Pcl5
were also shown using a co-IP experiment. We were also able to show the interaction with a cotransformation experiment when switching bait and prey. W, weak;
G, growth; M, Met; C, Cys; H, His. See text for more details. BCCM accession numbers are given; plasmids are accessible at the Belgian Co-ordinated Collections of
Microorganisms (BCCM; http://bccm.belspo.be/catalogues/genecorner-hosts).
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techniques are available to study PPIs, and since the ﬁrst description of the Y2H system
by Fields and Song (49), this system has been used to study thousands of PPIs for
hundreds of organisms (50, 51). Originally, the Y2H technique was used in small-scale
(low-throughput) studies in which speciﬁc interactions between often-known proteins
were studied using S. cerevisiae as the host organism (52, 53). Since then, the system
has been improved, changed, and adapted, leading to high-throughput screens and
even genome-wide studies (12, 50, 51, 54). The Y2H system is, however, a limited
system when studying C. albicans due to the differences in codon translation for the
CUG codon. To overcome the difference in codon usage, the CUG codons are some-
times substituted when using the Y2H system (55); however, this is not ideal. To
overcome this problem, a C2H system was created in 2010 (19). Here, we presented the
ﬁrst small-scale C2H high-throughput screening based on a mating approach. Using
one speciﬁc bait, Pho85, we tested a total of 1,478 out of 1,646 potential (90%)
interactions. The 168 potential interactions that could not be tested were caused by
failed mating due to either the prey not growing on the original SC-Arg plate or the
mating failing on Spider-plus-Dox plates. Current optimization in our lab has reduced
this problem, and a mating efﬁciency up to 95% is achievable. To eliminate the problem
of false positives, we applied a cautious two-step validation protocol. This reduced the
potential interactions from 15 to 5 and ﬁnally yielded one interaction between the
Pho85 and Pcl5 proteins. This interaction was further demonstrated in a low-scale
(cotransformation) C2H setup and also by swapping bait and prey. Finally, it was
validated by a co-IP experiment. The interaction was already described between the
homologues in S. cerevisiae, and the C. albicans Pcl5 was further described in the work
of Gildor et al. to be a putative Pho85 interactor (40). Our results now demonstrate the
physical interaction in C. albicans between the cyclin-dependent kinase Pho85 and the
cyclin Pcl5. Our lab is currently creating more prey- and bait-containing C. albicans
mating-compatible strains, and ongoing C2H experiments in our lab are performed to
screen several other baits against a random selection of 1,600 preys and are already
showing promising novel interactions. Our prey collection contains ﬁve orthologues of
S. cerevisiae proteins found to interact with ScPho85. Only for one of them could we
show a clear strong interaction in C. albicans. Either this may reﬂect physiological
differences between the two species, or the effect may also be caused by the technol-
ogy itself. In S. cerevisiae, the Y2H system is performed with a strong promoter coupled
with multicopy plasmids, resulting is very strong overexpression of the hybrid proteins.
This is not the case in C. albicans, where each construct is integrated in the genome.
The two-step validation approach and the use of a manual 96-replicate pinner,
however, currently limits the C2H system to smaller (manual) high-throughput screens.
Although partly limited at the moment, it will be possible to scale up the C2H technique
in the near future with adjustments so that an automated (robotic) approach can be
used. Together with the completion of a genome-wide prey and bait collection, this will
allow a genome-wide C2H screen of PPIs in C. albicans. Jointly with other techniques,
such as the vesicle capture interaction assay (27), BiFC (26), tandem afﬁnity puriﬁcation
(56, 57), and the “expanded genetic code” technique (28), the C2H system will bring us
another step closer to elucidating the C. albicans protein interaction network and
perhaps to the development of novel, very speciﬁc antifungals. The conﬁrmed PPI
found in this study will be uploaded to the BioGRID database (58), making it possible
to extend the protein-protein interaction network in C. albicans. With the results
presented here, we show the Candida community the potential of the C2H system to
investigate PPIs. C2H high-throughput screening can be applied to detect multiple
novel interactions, while the low-scale C2H system can be used to study putative
interactions.
MATERIALS AND METHODS
Strains and growth conditions. C. albicans strain SC2H3 (19) and its derivate mating-competent
strains SC2H3a-pWOR1 and SC2H3-pWOR1 (32) were used for the C2H system. These strains are
deposited in the Belgian Co-ordinated Collections of Microorganisms (BCCM). Accession numbers are
given in Table 2. Strain SC2H3 was used for the cotransformation validation step 2 of the high-
A High-Throughput Candida albicans Two-Hybrid System
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throughput study. Strains SC2H3a-pWOR1 and SC2H3-pWOR1 were used for the high-throughput study
and validation step 1. Strains were cultured at 23°C or 30°C on YPD medium (1% yeast extract, 2%
peptone, 2% dextrose, and 2% agar), Spider, or synthetic complete (SC) dropout medium from US
Biological, respectively; SC-arginine (SC-Arg) for prey-plasmid-harboring strains; SC-leucine (SC-Leu) for
bait-harboring strains; SC-Arg-Leu for strains with both prey and bait plasmids; SC-methionine-histidine
(SC-Met-His); and/or SC-methionine-cysteine-histidine (SC-Met-Cys-His) to check for potential interac-
tions. Preferably, high-quality medium is used (59). Omitting both methionine and cysteine will lead to
a higher expression of the bait and prey protein (34). All synthetic complete medium was pH adjusted
to 6.5 prior to autoclaving, and 2% agar was added. To induce the opaque state and mating, Spider
medium was supplemented with doxycycline (Spider plus Dox) (50 g Dox/ml) (32). Cells were grown at
23°C before and during mating; after mating, the cells were grown at 30°C for the high-throughput
experiment. For the cotransformation experiments, cells were grown at 30°C.
Escherichia coli strain MC1061 was used for plasmid propagation after the LR reaction took place. To
propagate the plasmid pC2HB-GC or pC2HP-GC, E. coli strain DB3.1 was used. Strains were cultured at
37°C in LB supplemented with 50 g/ml kanamycin (Kan) (prey or bait plasmid with ORF after LR
reaction), 50 g/ml kanamycin and 50 g/ml chloramphenicol (Cm) (pC2HB-GC or pC2HP-GC propaga-
tion), or 50 g/ml gentamicin (Gen) (pDONR207-XX). For solid medium, 2% agar was added. Table 2 gives
more details. Competent E. coli cells were made using the CaCl2 method.
Construction of the bait and prey two-hybrid plasmids and construction of the prey and bait
mating-compatible library. C. albicans ORFs were transferred from the pDONR207-XX plasmids into the
bait and prey two-hybrid vectors pC2HB-GC and pC2HP-GC using the Gateway LR reaction, yielding
pC2HB-XX or pC2HP-XX (32), respectively, according to the manual (Invitrogen) followed by transfor-
mation into chemically competent E. coli MC1061. Subsequently, the plasmids were digested with NotI
prior to being transformed into the mating-compatible strain SC2H3a-pWOR1 (for preys) or SC2H3-
pWOR1 (baits) with a lithium acetate transformation (19, 32) followed by plating on SC-Arg (for preys) or
SC-Leu (bait) medium. Resulting strains were stored at 80°C in 96-deep-well plates. When mating was
not necessary, plasmids were cotransformed into strain SC2H3 (both prey and bait plasmids) with a
lithium acetate transformation (19, 32).
High-throughput two-hybrid analysis and validation of the potentially identiﬁed interactions.
The high-throughput screen was performed as described in detail in Results. The ﬁrst steps were
performed at 23°C to prevent the cells from switching from the opaque state to the white state.
Doxycycline is added to the Spider medium to induce the opaque state. Further steps took place at 30°C.
Plates have to be wrapped with Paraﬁlm in all the steps except for the 2- to 3-day growth step at 30°C
on SC-Leu-Arg medium. For the ﬁnal step, to check for interaction, plates should be wrapped with at least
two layers of Paraﬁlm to prevent drying during a 14-day incubation at 30°C. The two-step validation
protocol was used to greatly reduce the amount of false positives. An extra step in which bait and prey
proteins are swapped can also be used as an extra control. The conﬁrmation of an interaction found
using the C2H can be achieved by using a different technique such as co-IP.
Protein extraction for Western blotting and coimmunoprecipitation. The protocol was based on
reference 19 with minor adjustments. Brieﬂy, overnight cultures were diluted to an optical density at 600
nm (OD600) of 0.5 in 50 ml and grown overnight to an OD600 of 5. Cells were collected by centrifugation
at 4°C for 5 min at 3,500 rpm, and the pellet was washed twice with ice-cold phosphate-buffered saline
(PBS; 140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4 at pH 7.3). Supernatant was removed,
and 500 l lysis buffer (PBS; 2 mM EDTA, 10% glycerol, 0.1% Triton X-100, 50 mM Tris, 10 mM NaF, 4 mM
Na3VO4, 10 mM -glycerophosphate and one tablet of Complete protease inhibitor cocktail [Roche]) and
glass beads were added. Cells were kept on ice for 5 min followed by bead beating (5 times for 30 s each
at 6 m/s), being put on ice for 1 min between cycles, to extract proteins. A coimmunoprecipitation was
performed with 500 g protein and Pierce antihemagglutinin (anti-HA) magnetic beads (Thermo Fisher)
by overnight incubation at 4°C. Following incubation, the beads were collected with a magnetic stand,
washed three times with lysis buffer followed by adding SDS sample buffer (5; 250 mM Tris-HCl, 10%
SDS, 0.5% bromophenol blue, 1.4 M -mercaptoethanol), and heated for 5 min at 95°C.
Proteins were separated by SDS-polyacrylamide gel electrophoresis on NuPAGE Novex Bis-Tris
minigels (Invitrogen) followed by transfer to a nitrocellulose membrane (Hybond C extra; Amersham).
Monoclonal anti-FLAG M2-peroxidase (horseradish peroxidase [HRP]) clone M2 was added for detection
of coimmunoprecipitated proteins. Signals were detected using SuperSignal West Pico Luminol solution
TABLE 2 Yeast and bacterial strains used in this study
Strain Genotype Reference BCCM accession no.
C. albicans
SC2H3 SN152 5xLexAOp-ADH1b/HIS1 5xLexAOp-ADH1b/lacZ 19 LMBP 10468
SC2H3a-pWOR1 SC2H3-MTLD::FRT  pNIM1-WOR1-NAT1 32 LMBP 10470
SC2H3-pWOR1 SC2H3  MTLaD::FRT  pNIM1-WOR1-NAT1 32 LMBP 10469
E. coli
MC1061 F Δ(araA-leu)7697 [araD139]B/r Δ(codB-lacI)3 galK16 galE15(GalS)  e14 mcrA0 relA1
rpsL150 spoT1 mcrB1 hsdR2
60 LMBP 472
DB3.1 gyrA462 endA1 Δ(sr1-recA) mcrB mrr hsdS20 glnV44 (supE44) ara14 galK2 lacY1 proA2
rpsL20 xyl5 leuB6 mtl1
61 LMBP 4098
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(Thermo Scientiﬁc). The immunoblots were imaged with Fujiﬁlm LAS-4000 Mini and the accompanying
software Image Reader LAS-4000 and Aida Image Analyzer v.4.22 (Life Sciences, Fuji, Photoﬁlm Co., Ltd.).
As a positive control, a coimmunoprecipitation step was performed with anti-FLAG magnetic beads
followed by detection of the protein using the anti-FLAG antibody.
Data availability. All plasmids and strains necessary to perform the C2H test are available from the
BCCM collection (http://bccm.belspo.be). The collection/accession numbers are given in Tables 1 and 2.
The pDONR207-XX plasmids containing the C. albicans ORFs (ORFeome) are available at the Centre
International de Ressources Microbiennes (CIRM; https://www6.inra.fr/cirm_eng/) (32).
The “empty” Gateway-adapted bait and prey plasmids (pCHB-GC and pCHP-GC), the generated bait
plasmids (pC2HB-Pho85 and pC2HB-Pcl5), and the interacting prey plasmids (pC2HP-Pcl5 and pC2HP-
Pho85) (and their plasmid maps) are accessible from the Belgian Co-ordinated Collections of Microor-
ganisms (BCCM; http://bccm.belspo.be). All LMBP accession numbers are provided in Tables 1 and 3.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mSphere.00391-18.
DATA SET S1, XLSX ﬁle, 0.1 MB.
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